| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +37% |
| 3Y CAGR | +62% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +82% |
| 3Y CAGR | +39% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,784.40 -97.10 (1.99%) | 22,313.00 | 30.35 | 5.31 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,477.60 -18.50 (0.74%) | 18,975.94 | 27.99 | 5.29 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,264.00 +32.00 (0.44%) | 18,050.13 | 106.41 | 20.68 | ||
Natco PharmaNATCOPHARM | ₹872.35 -11.70 (1.32%) | 15,823.46 | 13.82 | 1.72 |